[HTML][HTML] Screening for cervical cancer: Choices & dilemmas
S Rajaram, B Gupta - Indian Journal of Medical Research, 2021 - journals.lww.com
Cervical cancer is the fourth most common cancer in women in the world. To eliminate
cervical cancer by 2030, the World Health Organization has given the target of 70 per cent …
cervical cancer by 2030, the World Health Organization has given the target of 70 per cent …
Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized …
GS Ogilvie, D van Niekerk, M Krajden, LW Smith… - Jama, 2018 - jamanetwork.com
Importance There is limited information about the relative effectiveness of cervical cancer
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …
screening with primary human papillomavirus (HPV) testing alone compared with cytology in …
Women's attitudes towards a human papillomavirus-based cervical cancer screening strategy: a systematic review
J Nothacker, E Nury, MR Mathieu, H Raatz… - BMJ sexual & …, 2022 - srh.bmj.com
Objective To provide insights into women's attitudes towards a human papillomavirus (HPV)-
based cervical cancer screening strategy. Data sources Medline, Web of Science Core …
based cervical cancer screening strategy. Data sources Medline, Web of Science Core …
Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under-or never-screened women in Toronto, Ontario Canada
Background Cervical cancer is almost entirely preventable with appropriate and timely
screening. In Ontario, Canada, South Asian, Middle Eastern and North African women have …
screening. In Ontario, Canada, South Asian, Middle Eastern and North African women have …
Clinician and patient acceptability of self-collected human papillomavirus testing for cervical cancer screening
C Mao, SL Kulasingam, HK Whitham… - Journal of Women's …, 2017 - liebertpub.com
Background: To evaluate clinician and patient attitudes toward home self-collected human
papillomavirus (HPV) testing for cervical cancer screening. Methods: Women aged 21–65 …
papillomavirus (HPV) testing for cervical cancer screening. Methods: Women aged 21–65 …
Randomized intervention of self-collected sampling for human papillomavirus testing in under-screened rural women: uptake of screening and acceptability
CS Racey, DC Gesink, AN Burchell… - Journal of women's …, 2016 - liebertpub.com
Background: Our aim was to determine if cervical cancer screening uptake would increase
among under-screened women living in rural Ontario, Canada, if at-home self-collected …
among under-screened women living in rural Ontario, Canada, if at-home self-collected …
Barriers and facilitators to cervical cancer screening among women in rural Ontario, Canada: The role of self‐collected HPV testing
CS Racey, DC Gesink - The Journal of Rural Health, 2016 - Wiley Online Library
Purpose The addition of human papillomavirus (HPV) testing to primary cervical cancer
screening provides an opportunity to employ less invasive cervical cancer screening …
screening provides an opportunity to employ less invasive cervical cancer screening …
Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: a practical approach from Battor, Ghana
K Effah, E Tekpor, CM Wormenor… - PLOS Global Public …, 2023 - journals.plos.org
Cytology-based cervical cancer screening programs have been difficult to implement and
scale up in developing countries. Thus, the World Health Organization recommends a 'see …
scale up in developing countries. Thus, the World Health Organization recommends a 'see …
The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical …
DAM Heideman, AT Hesselink… - Journal of clinical …, 2013 - Am Soc Microbiol
ABSTRACT The Aptima HPV assay (Hologic Gen-Probe, San Diego, CA) is an FDA-
approved assay for detecting human papillomavirus (HPV) E6/E7 mRNA from 14 high-risk …
approved assay for detecting human papillomavirus (HPV) E6/E7 mRNA from 14 high-risk …
Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
GS Ogilvie, LW Smith, D van Niekerk, F Khurshed… - BMC public health, 2016 - Springer
Abstract Background High-risk HPV DNA testing has been proposed as a primary tool for
cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology …
cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology …